A Phase 3 combined drug/device rescue study in lower limb arterial bypass graft surgery, with 80 sites and over 1400 patients. The study was still enrolling when ProTrials assumed responsibility of this rescue study. Sites had been poorly trained on the protocol and use of the device, many sites were research naive, and data monitoring was significantly backlogged.